Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 94 entries
Sorted by: Best Match Show Resources per page
Impact of scaling and root planing with adjunct essential-oil-based mouthwash usage on whole salivary IgG levels in patients with periodontal inflammation.

Interventional medicine & applied science

Alshehri M, Altalhi A, Alqahtani HJ, Almoither MA, Alhazzani SA, Almohammadi MM, Kujan O.
PMID: 26767118
Interv Med Appl Sci. 2015 Dec;7(4):139-42. doi: 10.1556/1646.7.2015.4.1.

OBJECTIVE: The aim was to assess the effect of scaling and root planing (SRP) with and without adjunct use of an essential-oil-based-mouthwash (EOBM) on whole salivary immunoglobulin G (IgG) levels in patients with periodontal inflammation.METHODS: Fifty patients with periodontal...

Cite
Alshehri M, Altalhi A, Alqahtani HJ, et al. Impact of scaling and root planing with adjunct essential-oil-based mouthwash usage on whole salivary IgG levels in patients with periodontal inflammation. Interv Med Appl Sci. 2015;7(4):139-42doi: 10.1556/1646.7.2015.4.1.
Alshehri, M., Altalhi, A., Alqahtani, H. J., Almoither, M. A., Alhazzani, S. A., Almohammadi, M. M., & Kujan, O. (2015). Impact of scaling and root planing with adjunct essential-oil-based mouthwash usage on whole salivary IgG levels in patients with periodontal inflammation. Interventional medicine & applied science, 7(4), 139-42. https://doi.org/10.1556/1646.7.2015.4.1
Alshehri, Mohammad, et al. "Impact of scaling and root planing with adjunct essential-oil-based mouthwash usage on whole salivary IgG levels in patients with periodontal inflammation." Interventional medicine & applied science vol. 7,4 (2015): 139-42. doi: https://doi.org/10.1556/1646.7.2015.4.1
Alshehri M, Altalhi A, Alqahtani HJ, Almoither MA, Alhazzani SA, Almohammadi MM, Kujan O. Impact of scaling and root planing with adjunct essential-oil-based mouthwash usage on whole salivary IgG levels in patients with periodontal inflammation. Interv Med Appl Sci. 2015 Dec;7(4):139-42. doi: 10.1556/1646.7.2015.4.1. PMID: 26767118; PMCID: PMC4701163.
Copy Download .nbib Format: NLM
Effects of Targeting Higher VS Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants: The Canadian Oxygen Trial.

Journal of clinical neonatology

Al Hazzani F, Khadawardi E.
PMID: 24049746
J Clin Neonatol. 2013 Apr;2(2):70-2. doi: 10.4103/2249-4847.116403.

No abstract available.

Cite
Al Hazzani F, Khadawardi E. Effects of Targeting Higher VS Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants: The Canadian Oxygen Trial. J Clin Neonatol. 2013;2(2):70-2doi: 10.4103/2249-4847.116403.
Al Hazzani, F., & Khadawardi, E. (2013). Effects of Targeting Higher VS Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants: The Canadian Oxygen Trial. Journal of clinical neonatology, 2(2), 70-2. https://doi.org/10.4103/2249-4847.116403
Al Hazzani, Fahad, and Khadawardi, Emad. "Effects of Targeting Higher VS Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants: The Canadian Oxygen Trial." Journal of clinical neonatology vol. 2,2 (2013): 70-2. doi: https://doi.org/10.4103/2249-4847.116403
Al Hazzani F, Khadawardi E. Effects of Targeting Higher VS Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants: The Canadian Oxygen Trial. J Clin Neonatol. 2013 Apr;2(2):70-2. doi: 10.4103/2249-4847.116403. PMID: 24049746; PMCID: PMC3775138.
Copy Download .nbib Format: NLM
Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.

Intensive care medicine

Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M, Perner A, Møller MH, Krag M, Almenawer S, Rochwerg B, Dionne J, Jaeschke R, Alshahrani M, Deane A, Perri D, Thebane L, Al-Omari A, Finfer S, Cook D, Guyatt G.
PMID: 29230521
Intensive Care Med. 2018 Feb;44(2):277-278. doi: 10.1007/s00134-017-5023-6.

Owing to an oversight by the authors, all the figures in the last column of Table 2 (upper section: Number needed to treat; lower section: Number needed to harm) in this article were given without the final digit 0...

Cite
Alhazzani W, Alshamsi F, Belley-Cote E, et al. Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018;44(2):277-278doi: 10.1007/s00134-017-5023-6.
Alhazzani, W., Alshamsi, F., Belley-Cote, E., Heels-Ansdell, D., Brignardello-Petersen, R., Alquraini, M., Perner, A., Møller, M. H., Krag, M., Almenawer, S., Rochwerg, B., Dionne, J., Jaeschke, R., Alshahrani, M., Deane, A., Perri, D., Thebane, L., Al-Omari, A., Finfer, S., Cook, D., & Guyatt, G. (2018). Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive care medicine, 44(2), 277-278. https://doi.org/10.1007/s00134-017-5023-6
Alhazzani, Waleed, et al. "Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials." Intensive care medicine vol. 44,2 (2018): 277-278. doi: https://doi.org/10.1007/s00134-017-5023-6
Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M, Perner A, Møller MH, Krag M, Almenawer S, Rochwerg B, Dionne J, Jaeschke R, Alshahrani M, Deane A, Perri D, Thebane L, Al-Omari A, Finfer S, Cook D, Guyatt G. Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018 Feb;44(2):277-278. doi: 10.1007/s00134-017-5023-6. PMID: 29230521; PMCID: PMC6828280.
Copy Download .nbib Format: NLM
Preference and Values of Stroke Interventions, Kingdom of Saudi Arabia.

Neurology research international

Alamri R, Alhazzani A, Alqahtani SA, Al-Alfard H, Mukhtar S, Alshahrany K, Asiri F.
PMID: 31057967
Neurol Res Int. 2019 Apr 01;2019:8502758. doi: 10.1155/2019/8502758. eCollection 2019.

No abstract available.

Cite
Alamri R, Alhazzani A, Alqahtani SA, et al. Preference and Values of Stroke Interventions, Kingdom of Saudi Arabia. Neurol Res Int. 2019;2019:8502758doi: 10.1155/2019/8502758.
Alamri, R., Alhazzani, A., Alqahtani, S. A., Al-Alfard, H., Mukhtar, S., Alshahrany, K., & Asiri, F. (2019). Preference and Values of Stroke Interventions, Kingdom of Saudi Arabia. Neurology research international, 20198502758. https://doi.org/10.1155/2019/8502758
Alamri, Reem, et al. "Preference and Values of Stroke Interventions, Kingdom of Saudi Arabia." Neurology research international vol. 2019 (2019): 8502758. doi: https://doi.org/10.1155/2019/8502758
Alamri R, Alhazzani A, Alqahtani SA, Al-Alfard H, Mukhtar S, Alshahrany K, Asiri F. Preference and Values of Stroke Interventions, Kingdom of Saudi Arabia. Neurol Res Int. 2019 Apr 01;2019:8502758. doi: 10.1155/2019/8502758. eCollection 2019. PMID: 31057967; PMCID: PMC6463561.
Copy Download .nbib Format: NLM
Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia.

Multiple sclerosis international

Bunyan R, Al Towaijri G, Al Otaibi H, Kareem A, Algahtani H, Al Mejally M, Almubarak A, Alrajeh S, Cupler E, Qureshi S, Alawi S, Kalakatawi M, Al Malik Y, Nahrir S, Alhazzani A, El-Metwally A, Shami S, Ishak S, Almudaiheem H, Al-Jedai A, AlJumah M.
PMID: 34796030
Mult Scler Int. 2021 Nov 09;2021:4226141. doi: 10.1155/2021/4226141. eCollection 2021.

BACKGROUND: The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, data on the pediatric onset of MS is lacking, particularly in developing countries.OBJECTIVE: This study is aimed at reporting the current burden of the pediatric onset...

Cite
Bunyan R, Al Towaijri G, Al Otaibi H, et al. Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia. Mult Scler Int. 2021;2021:4226141doi: 10.1155/2021/4226141.
Bunyan, R., Al Towaijri, G., Al Otaibi, H., Kareem, A., Algahtani, H., Al Mejally, M., Almubarak, A., Alrajeh, S., Cupler, E., Qureshi, S., Alawi, S., Kalakatawi, M., Al Malik, Y., Nahrir, S., Alhazzani, A., El-Metwally, A., Shami, S., Ishak, S., Almudaiheem, H., Al-Jedai, A., & AlJumah, M. (2021). Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia. Multiple sclerosis international, 20214226141. https://doi.org/10.1155/2021/4226141
Bunyan, Reem, et al. "Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia." Multiple sclerosis international vol. 2021 (2021): 4226141. doi: https://doi.org/10.1155/2021/4226141
Bunyan R, Al Towaijri G, Al Otaibi H, Kareem A, Algahtani H, Al Mejally M, Almubarak A, Alrajeh S, Cupler E, Qureshi S, Alawi S, Kalakatawi M, Al Malik Y, Nahrir S, Alhazzani A, El-Metwally A, Shami S, Ishak S, Almudaiheem H, Al-Jedai A, AlJumah M. Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia. Mult Scler Int. 2021 Nov 09;2021:4226141. doi: 10.1155/2021/4226141. eCollection 2021. PMID: 34796030; PMCID: PMC8595009.
Copy Download .nbib Format: NLM
Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice.

Pharmaceutics

Alhazzani K, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Sarawi W, Alqarni SA, Algahtani M, Nadeem A.
PMID: 34206429
Pharmaceutics. 2021 Jun 22;13(7). doi: 10.3390/pharmaceutics13070925.

Multiple sclerosis (MS) is an immune-mediated inflammatory disease that leads to demyelination and neuronal loss in the central nervous system. Immune cells of lymphoid and myeloid origin play a significant role in the initiation and amplification of neuronal inflammation...

Cite
Alhazzani K, Ahmad SF, Al-Harbi NO, et al. Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice. Pharmaceutics. 2021;13(7)doi: 10.3390/pharmaceutics13070925.
Alhazzani, K., Ahmad, S. F., Al-Harbi, N. O., Attia, S. M., Bakheet, S. A., Sarawi, W., Alqarni, S. A., Algahtani, M., & Nadeem, A. (2021). Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice. Pharmaceutics, 13(7), . https://doi.org/10.3390/pharmaceutics13070925
Alhazzani, Khalid, et al. "Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice." Pharmaceutics vol. 13,7 (2021). doi: https://doi.org/10.3390/pharmaceutics13070925
Alhazzani K, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Sarawi W, Alqarni SA, Algahtani M, Nadeem A. Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice. Pharmaceutics. 2021 Jun 22;13(7). doi: 10.3390/pharmaceutics13070925. PMID: 34206429; PMCID: PMC8308768.
Copy Download .nbib Format: NLM
Management of Diabetic Foot Ulcers Using Topical Oxygen Therapy: A Case Series.

Current diabetes reviews

Tabanjeh SF, Al-Malki T, Alhazzani AR, Robert AA.
PMID: 34636303
Curr Diabetes Rev. 2021 Oct 04; doi: 10.2174/1573399817666211005094414. Epub 2021 Oct 04.

BACKGROUND AND AIM: Surgical and endovascular revascularization procedures along with hyperbaric oxygen therapy (HBOT) and topical oxygen therapy (TOT) for chronic oxygen-deprived wounds are standard care treatment protocols for diabetic foot ulcer (DFU). Topical developments in the delivery of...

Cite
Tabanjeh SF, Al-Malki T, Alhazzani AR, et al. Management of Diabetic Foot Ulcers Using Topical Oxygen Therapy: A Case Series. Curr Diabetes Rev. 2021;doi: 10.2174/1573399817666211005094414.
Tabanjeh, S. F., Al-Malki, T., Alhazzani, A. R., & Robert, A. A. (2021). Management of Diabetic Foot Ulcers Using Topical Oxygen Therapy: A Case Series. Current diabetes reviews, . https://doi.org/10.2174/1573399817666211005094414
Tabanjeh, Sinan F, et al. "Management of Diabetic Foot Ulcers Using Topical Oxygen Therapy: A Case Series." Current diabetes reviews vol. (2021). doi: https://doi.org/10.2174/1573399817666211005094414
Tabanjeh SF, Al-Malki T, Alhazzani AR, Robert AA. Management of Diabetic Foot Ulcers Using Topical Oxygen Therapy: A Case Series. Curr Diabetes Rev. 2021 Oct 04; doi: 10.2174/1573399817666211005094414. Epub 2021 Oct 04. PMID: 34636303.
Copy Download .nbib Format: NLM
Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia over a decade.

Journal of neonatal-perinatal medicine

Al Hazzani F, Al-Alaiyan S, Kattan A, Binmanee A, Jabr MB, Al Midani E, Khadawardi E, Riaz F, Elsaidawi W.
PMID: 33337393
J Neonatal Perinatal Med. 2021;14(3):427-432. doi: 10.3233/NPM-200534.

BACKGROUND: Knowledge on short-term outcomes of preterm infants is important for quality control. Our objective was to analyze the outcomes of very low birth weight infants admitted to our neonatal intensive care unit over a ten years' period and...

Cite
Al Hazzani F, Al-Alaiyan S, Kattan A, et al. Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia over a decade. J Neonatal Perinatal Med. 2021;14(3):427-432doi: 10.3233/NPM-200534.
Al Hazzani, F., Al-Alaiyan, S., Kattan, A., Binmanee, A., Jabr, M. B., Al Midani, E., Khadawardi, E., Riaz, F., & Elsaidawi, W. (2021). Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia over a decade. Journal of neonatal-perinatal medicine, 14(3), 427-432. https://doi.org/10.3233/NPM-200534
Al Hazzani, F, et al. "Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia over a decade." Journal of neonatal-perinatal medicine vol. 14,3 (2021): 427-432. doi: https://doi.org/10.3233/NPM-200534
Al Hazzani F, Al-Alaiyan S, Kattan A, Binmanee A, Jabr MB, Al Midani E, Khadawardi E, Riaz F, Elsaidawi W. Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia over a decade. J Neonatal Perinatal Med. 2021;14(3):427-432. doi: 10.3233/NPM-200534. PMID: 33337393.
Copy Download .nbib Format: NLM
Convalescent Plasma in COVID-19: To what Degree should Clinicians Rely on Currently Available Data?.

Saudi journal of medicine & medical sciences

Alhazzani W, Jaeschke R.
PMID: 33519336
Saudi J Med Med Sci. 2021 Jan-Apr;9(1):1-2. doi: 10.4103/sjmms.sjmms_882_20. Epub 2020 Dec 26.

No abstract available.

Cite
Alhazzani W, Jaeschke R. Convalescent Plasma in COVID-19: To what Degree should Clinicians Rely on Currently Available Data?. Saudi J Med Med Sci. 2020;9(1):1-2doi: 10.4103/sjmms.sjmms_882_20.
Alhazzani, W., & Jaeschke, R. (2021). Convalescent Plasma in COVID-19: To what Degree should Clinicians Rely on Currently Available Data?. Saudi journal of medicine & medical sciences, 9(1), 1-2. https://doi.org/10.4103/sjmms.sjmms_882_20
Alhazzani, Waleed, and Jaeschke, Roman. "Convalescent Plasma in COVID-19: To what Degree should Clinicians Rely on Currently Available Data?." Saudi journal of medicine & medical sciences vol. 9,1 (2021): 1-2. doi: https://doi.org/10.4103/sjmms.sjmms_882_20
Alhazzani W, Jaeschke R. Convalescent Plasma in COVID-19: To what Degree should Clinicians Rely on Currently Available Data?. Saudi J Med Med Sci. 2021 Jan-Apr;9(1):1-2. doi: 10.4103/sjmms.sjmms_882_20. Epub 2020 Dec 26. PMID: 33519336; PMCID: PMC7839581.
Copy Download .nbib Format: NLM
Oxygenation targets in acutely ill patients: still a matter of debate - Authors' reply.

Lancet (London, England)

Chu DK, Kim LH, Neary JD, Szczeklik W, Alhazzani W.
PMID: 30527414
Lancet. 2018 Dec 08;392(10163):2437-2438. doi: 10.1016/S0140-6736(18)32168-8.

No abstract available.

Cite
Chu DK, Kim LH, Neary JD, et al. Oxygenation targets in acutely ill patients: still a matter of debate - Authors' reply. Lancet. 2018;392(10163):2437-2438doi: 10.1016/S0140-6736(18)32168-8.
Chu, D. K., Kim, L. H., Neary, J. D., Szczeklik, W., & Alhazzani, W. (2018). Oxygenation targets in acutely ill patients: still a matter of debate - Authors' reply. Lancet (London, England), 392(10163), 2437-2438. https://doi.org/10.1016/S0140-6736(18)32168-8
Chu, Derek K, et al. "Oxygenation targets in acutely ill patients: still a matter of debate - Authors' reply." Lancet (London, England) vol. 392,10163 (2018): 2437-2438. doi: https://doi.org/10.1016/S0140-6736(18)32168-8
Chu DK, Kim LH, Neary JD, Szczeklik W, Alhazzani W. Oxygenation targets in acutely ill patients: still a matter of debate - Authors' reply. Lancet. 2018 Dec 08;392(10163):2437-2438. doi: 10.1016/S0140-6736(18)32168-8. PMID: 30527414.
Copy Download .nbib Format: NLM
Saccharin and naltrexone prevent increased pain sensitivity and impaired long-term memory induced by repetitive neonatal noxious stimulation: role of BDNF and enkephalin.

Naunyn-Schmiedeberg's archives of pharmacology

Nuseir KQ, Alzoubi KH, Alhusban AY, Alazzani M, Bawaane A, Khabour OF.
PMID: 33829293
Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1641-1650. doi: 10.1007/s00210-021-02086-2. Epub 2021 Apr 08.

This study aim to examine the hypothesis that repetitive painful stimuli during infancy will alter pain sensitivity and impair learning and memory during adulthood and that saccharin will prevent this through its analgesic effect. Naltrexone is used to examine...

Cite
Nuseir KQ, Alzoubi KH, Alhusban AY, et al. Saccharin and naltrexone prevent increased pain sensitivity and impaired long-term memory induced by repetitive neonatal noxious stimulation: role of BDNF and enkephalin. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(8):1641-1650doi: 10.1007/s00210-021-02086-2.
Nuseir, K. Q., Alzoubi, K. H., Alhusban, A. Y., Alazzani, M., Bawaane, A., & Khabour, O. F. (2021). Saccharin and naltrexone prevent increased pain sensitivity and impaired long-term memory induced by repetitive neonatal noxious stimulation: role of BDNF and enkephalin. Naunyn-Schmiedeberg's archives of pharmacology, 394(8), 1641-1650. https://doi.org/10.1007/s00210-021-02086-2
Nuseir, Khawla Q, et al. "Saccharin and naltrexone prevent increased pain sensitivity and impaired long-term memory induced by repetitive neonatal noxious stimulation: role of BDNF and enkephalin." Naunyn-Schmiedeberg's archives of pharmacology vol. 394,8 (2021): 1641-1650. doi: https://doi.org/10.1007/s00210-021-02086-2
Nuseir KQ, Alzoubi KH, Alhusban AY, Alazzani M, Bawaane A, Khabour OF. Saccharin and naltrexone prevent increased pain sensitivity and impaired long-term memory induced by repetitive neonatal noxious stimulation: role of BDNF and enkephalin. Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1641-1650. doi: 10.1007/s00210-021-02086-2. Epub 2021 Apr 08. PMID: 33829293.
Copy Download .nbib Format: NLM
Predictors of Opioid Prescription Among a Sample of Patients with Acute Musculoskeletal Pain at a Tertiary Care Hospital in Saudi Arabia.

Journal of pain research

AlRuthia Y, Alhazzani H, Alhindi G, Alarfaj M, Almutairi L, Alanazi M, Alokili K, Alanazi N, Alodaibi F, Alwhaibi M, Bashatah AS, Asiri Y, Alsanawi H.
PMID: 33235491
J Pain Res. 2020 Nov 16;13:2929-2936. doi: 10.2147/JPR.S276630. eCollection 2020.

BACKGROUND: Musculoskeletal pain is one of the most complex and debilitating types of pain. Although different pharmacologic treatments are available, very few studies have explored the predictors for opioid analgesics prescription to manage this type of pain.OBJECTIVE: The aim...

Cite
AlRuthia Y, Alhazzani H, Alhindi G, et al. Predictors of Opioid Prescription Among a Sample of Patients with Acute Musculoskeletal Pain at a Tertiary Care Hospital in Saudi Arabia. J Pain Res. 2020;13:2929-2936doi: 10.2147/JPR.S276630.
AlRuthia, Y., Alhazzani, H., Alhindi, G., Alarfaj, M., Almutairi, L., Alanazi, M., Alokili, K., Alanazi, N., Alodaibi, F., Alwhaibi, M., Bashatah, A. S., Asiri, Y., & Alsanawi, H. (2020). Predictors of Opioid Prescription Among a Sample of Patients with Acute Musculoskeletal Pain at a Tertiary Care Hospital in Saudi Arabia. Journal of pain research, 132929-2936. https://doi.org/10.2147/JPR.S276630
AlRuthia, Yazed, et al. "Predictors of Opioid Prescription Among a Sample of Patients with Acute Musculoskeletal Pain at a Tertiary Care Hospital in Saudi Arabia." Journal of pain research vol. 13 (2020): 2929-2936. doi: https://doi.org/10.2147/JPR.S276630
AlRuthia Y, Alhazzani H, Alhindi G, Alarfaj M, Almutairi L, Alanazi M, Alokili K, Alanazi N, Alodaibi F, Alwhaibi M, Bashatah AS, Asiri Y, Alsanawi H. Predictors of Opioid Prescription Among a Sample of Patients with Acute Musculoskeletal Pain at a Tertiary Care Hospital in Saudi Arabia. J Pain Res. 2020 Nov 16;13:2929-2936. doi: 10.2147/JPR.S276630. eCollection 2020. PMID: 33235491; PMCID: PMC7678505.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 94 entries